Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
12/12/1996 | CA2210193A1 Treatment of traveller's diarrhea |
12/11/1996 | EP0747482A2 Hepatitis GB virus recombinant proteins and uses thereof |
12/11/1996 | EP0747386A2 Method and antisense oligonucleotides to Interleukin-6 receptor mRNA for inhibiting cellular proliferation |
12/11/1996 | EP0747383A2 Polyamine salts of clavulanic acid |
12/11/1996 | EP0747381A1 Carbapenem derivative |
12/11/1996 | EP0747368A1 Derivatives of monocyclic polyamines, their preparation, and their use as antiviral agents |
12/11/1996 | EP0747363A1 Anti-viral benzimidazole derivatives |
12/11/1996 | EP0747351A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof |
12/11/1996 | EP0747062A2 Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same |
12/11/1996 | EP0747058A1 Acellular vaccine |
12/11/1996 | EP0747051A2 Methods of inducing BEF-1 transcription factor |
12/11/1996 | EP0747047A1 Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent |
12/11/1996 | EP0746624A1 Vector for liver-specific gene therapy |
12/11/1996 | EP0746568A1 Method for the preparation of glycopeptidic antibiotic precursors by intramolecular cyclisation and formation of a biaryl ether bridge and novel compounds so obtained |
12/11/1996 | EP0746564A1 4-n-substituted sialic acids and their sialosides |
12/11/1996 | EP0746559A1 Pyrrolo(2,3-d)pyrimidine derivatives as antivirals |
12/11/1996 | EP0746558A1 Phenylalkylamino derivatives of condensed carbapenemes |
12/11/1996 | EP0746557A1 Intracellular signalling mediators |
12/11/1996 | EP0746542A1 Therapeutic benzonitriles |
12/11/1996 | EP0746338A1 Vaccines containing paucilamellar lipid vesicles as immunological adjuvants |
12/11/1996 | EP0746336A1 Prodrugs activated by targeted catalytic proteins |
12/11/1996 | EP0746333A1 Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv) |
12/11/1996 | EP0746327A1 Acidified nitrite as an antimicrobial agent |
12/11/1996 | EP0746320A1 Hiv protease inhibitors and intermediates |
12/11/1996 | EP0746319A1 Acyclovir derivatives for topical use |
12/11/1996 | EP0746312A1 Guanylhydrazones for treating inflammatory conditions |
12/11/1996 | EP0695305A4 Method of forming oligonucleotides |
12/11/1996 | EP0644887B1 Intermediates in a process for the purification of clavulanic acid |
12/11/1996 | EP0491865B1 Conjugate vaccine for group b streptococcus |
12/11/1996 | EP0437556B1 Substitution analogues of magainin peptides |
12/11/1996 | CN1137400A Method for preparation of drug for curing acute epidemic febrile disease |
12/10/1996 | US5583248 Amino acid derivatives having antiviral activity |
12/10/1996 | US5583226 Chemical intermediates of viricidal nucleotides |
12/10/1996 | US5583221 Antiinflammatory agents, cardiovascular disorders, viricides, fungicides |
12/10/1996 | US5583148 Bis-acyloxymethyl derivatives |
12/10/1996 | US5583132 Hiv infections, aids |
12/10/1996 | US5583131 For treatment or prevention of acquired immune deficiency syndrome, reduced toxicity |
12/10/1996 | US5583125 25-Carboxylic acid derivatives in the vitamin D series, process for their production, intermediate products for these processes, pharmaceutical preparations containing these derivatives as well as their use for the production of pharmaceutical agents |
12/10/1996 | US5583115 Dialkyltiacumicin compounds |
12/10/1996 | US5583105 Oral pharmaceutical preparation |
12/10/1996 | US5583038 Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins |
12/10/1996 | US5583018 Rapamycin derivative process for its preparation and its use |
12/10/1996 | US5582990 Nucleotide sequence which codes antigen used for detection of lyme disease |
12/10/1996 | CA2114727C Quinoline derivatives as immunostimulants |
12/10/1996 | CA2082270C Anti-viral therapy |
12/10/1996 | CA2023217C Azabicyclo quinolone carboxylic acids |
12/10/1996 | CA1338780C Water-soluble antibiotic composition and water-soluble salts of new cephem compounds |
12/08/1996 | CA2178537A1 Hepatitis gb virus recombinant proteins and uses thereof |
12/05/1996 | WO1996038565A1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER |
12/05/1996 | WO1996038548A1 Oxygen activatable formulations for disinfection or sterilization |
12/05/1996 | WO1996038475A1 Helicobacter pylori antigens and vaccine compositions |
12/05/1996 | WO1996038474A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide |
12/05/1996 | WO1996038473A2 Antimicrobial cationic peptides |
12/05/1996 | WO1996038461A1 Cleavage of rna using metal complexes |
12/05/1996 | WO1996038460A1 Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide |
12/05/1996 | WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
12/05/1996 | WO1996038426A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
12/05/1996 | WO1996038417A1 N-oxides as antibacterial agents |
12/05/1996 | WO1996038174A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
12/05/1996 | WO1996038171A1 Methods of raising antibodies against e.coli of the family cs4-cfa/1 |
12/05/1996 | WO1996038162A1 Method of using lectins for prevention and treatment of skin diseases and disorders |
12/05/1996 | WO1996038150A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds |
12/05/1996 | WO1996038147A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin |
12/05/1996 | WO1996038144A1 Isothiazolones |
12/05/1996 | WO1996038115A1 Method of using lectins for agglutination and collection of menstrual flow |
12/05/1996 | DE19519822A1 Neue antibakterielle Mittel New antibacterial agents |
12/05/1996 | CA2762921A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
12/05/1996 | CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
12/05/1996 | CA2222968A1 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide |
12/05/1996 | CA2222797A1 Helicobacter pylori antigens and vaccine compositions |
12/05/1996 | CA2222689A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin |
12/05/1996 | CA2222599A1 Antimicrobial cationic peptides |
12/05/1996 | CA2222561A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds |
12/05/1996 | CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
12/05/1996 | CA2221128A1 Hydrolysis and photocleavage of nucleic acid using a metal complex |
12/05/1996 | CA2218253A1 Isothiazolones |
12/04/1996 | EP0745852A1 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy |
12/04/1996 | EP0745128A1 Hepatitis b virus mutants, reagents and methods for detection |
12/04/1996 | EP0745127A1 Control of marek's disease by the inhibition of latency and tumor cell development |
12/04/1996 | EP0745083A1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION |
12/04/1996 | EP0745065A1 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics |
12/04/1996 | EP0744955A1 Cyclic heptapeptide anti-inflammatory agent |
12/04/1996 | EP0744948A1 Protease inhibitors |
12/04/1996 | EP0744894A1 Self-assembling multimeric nucleic acid constructs |
12/04/1996 | EP0578644B1 Antibiotic a 40926 ester derivatives |
12/04/1996 | CN1137275A O-aryl O-alkyl O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity |
12/04/1996 | CN1137273A Quinolizinone type compounds |
12/04/1996 | CN1137268A Amidino derivatives useful as nitric oxide synthase inhibitors |
12/04/1996 | CN1136928A Red sage root use for antivirus of AIDS and hepatitis B |
12/04/1996 | CN1033455C 1-methylcarbapenem derivatives and process for preparation thereof |
12/04/1996 | CN1033451C Alpha-substituted benzenemethanamine derivatives |
12/03/1996 | US5580884 Antimicrobial agents |
12/03/1996 | US5580881 1,2,3,5,6,7,8,8a-Octahydro-5,5,8a-trimethyl-(8aβ)-6-isoquinolineamine derivatives, preparation method therefor and therapeutical use thereof |
12/03/1996 | US5580860 Pharmaceutical composition containing 2-amino-6-chloropurine-9-β-D-2',3'-dideoxyribofuranoxside |
12/03/1996 | US5580767 Some of internucleotide linkages within oligonucleotide are phosphorothioate linkages |
12/03/1996 | US5580739 Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2 |
12/03/1996 | US5580297 Royal jelly |
12/03/1996 | CA2028140C Novel bacteriocin compositions for use as enhanced broad range |
12/03/1996 | CA1338764C Polyamine derivatives |
11/28/1996 | WO1996037624A1 A method for producing influenza hemagglutinin multivalent vaccines |